- 4-FMA
- 4-Fluoromethamphetamine
- 4F-MA
- 4-Fluoro-N-methylamphetamine
- PFMA
Rõsner, P; Quednow, B; Girreser, U; Junge, T. Isomeric fluoro-methoxy-phenylalkylamines: A new series of controlled-substance analogues (designer drugs) Forensic Sci. Int., 1 Jan 2004, 148 (2–3), 143–156. 282 kB. https://doi.org/10.1016/j.forsciint.2004.05.003 #6 MS,NMR,IR
Westphal, F; Rõsner, P; Junge, T. Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry Forensic Sci. Int., 30 Jan 2010, 194 (1–3), 53–59. 521 kB. https://doi.org/10.1016/j.forsciint.2009.10.007 MS
Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. https://doi.org/10.1016/j.forsciint.2011.11.003
Segawa, H; Iwata, YT; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Kanamori, T; Inoue, H. Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography: Differentiation of ring-substituted regioisomers by supercritical fluid chromatography Drug Test. Anal., 1 Mar 2017, 9 (3), 389-398. 1.3 MB. https://doi.org/10.1002/dta.2040 #4-F-MA UV,other
Ogino, M; Naiki, T; Orui, H; Kosone, K; Yamazaki, M. Study of method for identifying phenethylamine drugs JCCL, 11 Feb 2011, 50, 63-82. 627 kB. Japanese, English abstract LC,MS,NMR,IR
EMCDDA. New drugs in Europe, 2010, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2011. 700 kB.
Patrick, TM; McBee, ET; Hass, HB. Synthesis of arylpropylamines. I. From allyl chloride J. Am. Chem. Soc., 1 Jun 1946, 68 (6), 1009-1011. 376 kB. https://doi.org/10.1021/ja01210a032 #N-Methyl-1-(p-fluorophenyl)-2-propylamine
Vidal Giné, C; Espinosa, IF; Vilamala, MV. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Test. Anal., 1 Jul 2014, 6 (7-8), 819-824. 113 kB. https://doi.org/10.1002/dta.1610
King, LA. New phenethylamines in Europe Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
Simmler, LD; Liechti, ME. Pharmacology of MDMA- and amphetamine-like new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 143-164. 298 kB. https://doi.org/10.1007/164_2018_113
Grumann, C; Auwärter, V. Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry Drug Test. Anal., 1 Jul 2018, 10 (7), 1184–1191. 861 kB. https://doi.org/10.1002/dta.2371 #4-FMA LC,MS
Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry Talanta, 15 Feb 2009, 77 (4), 1245–1272. 1.2 MB. https://doi.org/10.1016/j.talanta.2008.07.062 #N-Me-4FMP GC,LC,MS,UV
Nagashima, M; Seto, T; Takahashi, M; Suzuki, J; Yasuda, I. Spectrum data of the 3rd Governor-designated drugs and the analyses of uncontrolled drugs purchased Apr. 2005 – Mar. 2006 Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2006, 57 109–113. 394 kB. #4FMA LC,NMR,IR,UV
Rickli, A; Hoener, MC; Liechti, ME. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones Eur. Neuropsychopharmacol., 1 Mar 2015, 25 (3), 365–376. 1.6 MB. https://doi.org/10.1016/j.euroneuro.2014.12.012 #4-Fluoromethamphetamine
Luethi, D; Liechti, ME. Monoamine transporter and receptor interaction profiles in vitro predict reported human doses of novel psychoactive stimulants and psychedelics Int. J. Neuropsychoph., 1 Oct 2018, 21 (10), 926–931. 254 kB. https://doi.org/10.1093/ijnp/pyy047 #S1 Phenethylamines 4-Fluorometha
Bork, W; Dahlenburg, R; Gimbel, M; Jacobsen-Bauer, A; Zörntlein, S. Herleitung Von Grenzwerten Der „nicht Geringen Menge“ Im Sinne Des Btmg Toxichem Krimtech, 1 Jan 2019, 86 (1), 5–91. 4.4 MB. #PP-013
Matsushita, T; Ishibashi, H; Morio, H. Study on methods to discriminate the stimulant analogues fluoroamphetamines and fluoromethamphetamines JCCL, 1 Sep 2014, (54), 91–103. 582 kB. #4-FMA Japanese, English abstract GC,MS,IR,TLC
Sanuki, K; Orui, H; Fujii, T; Kurashima, N; Ikehara, Y. Synthesis and analysis of phenethylamine analogues JCCL, 1 Nov 2007, (47), 33–39. 2.0 MB. #4-FMA Japanese, English abstract LC,MS,NMR,IR,UV,other
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #A14 LC
Clancy, L; Philp, M; Shimmon, R; Fu, S. Development and validation of a color spot test method for the presumptive detection of 25-NBOMe compounds Drug Test. Anal., 19 Aug 2020, 13 (5), 929-943. 11.3 MB. https://doi.org/10.1002/dta.2905 #4-fluoromethamphetamine spot
Nahoko, U; Norimasa, M; Maiko, K; Ruri, K; Yukihiro, G. Analysis of newly distributed designer drugs detected in the products purchased in fiscal year 2008 Yakugaku Zasshi, 1 Feb 2010, 130 (2), 263–270. 826 kB. https://doi.org/10.1248/yakushi.130.263 #N-Me-4-FMP GC,LC,MS,NMR,UV
Nahoko, U; Ruri, K; Nobuo, K; Yukihiro, G. Analysis of designer drugs detected in the products purchased in fiscal year 2006 Yakugaku Zasshi, 1 Jan 2008, 128 (10), 1499–1505. 604 kB. https://doi.org/10.1248/yakushi.128.1499 #N-Me-4-FMP GC,LC,MS,NMR
Philp, M; Shimmon, R; Stojanovska, N; Tahtouh, M; Fu, S. Development and validation of a presumptive colour spot test method for the detection of piperazine analogues in seized illicit materials Anal. Methods, 1 Jan 2013, 5 (20), 5402. 783 kB. https://doi.org/10.1039/c3ay40511g #4-Fluoromethamphetamine MS,NMR,IR,spot